Technology Center 1600 is the home for life science patent applications at the USPTO. This includes applications related to organic compounds, organic chemistry, molecular biology, immunology, fermentation, and plants.

Technology Center 2400 handles data processing and telecommunications technologies, including multiplex and VoIP, cable and television, recording and compression, cryptography and security, and computer networks.

In our analysis, we found that the First Action Interview Pilot Program (FAIPP) may not result in a faster prosecution, but it is effective in reaching an allowance with fewer office actions.

Technology Center 2800 handles a wide range of electrical technologies, including semiconductors, circuits, optics, and printing.

We are in the middle of a professional paradigm shift - adapting to the new normal of a fully or partially remote workforce. This could be the motivation the patent industry needs to fully lean into the possibilities of legal technology.

In early June, AstraZeneca approached rival drugmaker Gilead Sciences to discuss a potential merger. Though some doubt the feasibility of such a deal, this would be the biggest healthcare merger on record.

On this year’s World IP Day, WIPO Director General Francis Gurry called for a surge in green tech patenting to fight climate change. His charge follows a report that patenting for green energy technologies has slowed.

As legal tech revolutionizes the industry, offering new avenues for speed, accuracy, and quality assurance in legal work, often, one roadblock remains - the budget-minded CFO.

Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to sell some properties if they commence a planned merger.

Big business is all about data. We see it in almost every industry, from healthcare to financial services to aviation and beyond. But the legal industry has been slow to adapt.